Report Overview
The global Ibuprofen API Market refers to the industry that focuses on the production and supply of Active Pharmaceutical Ingredients (API) used to manufacture ibuprofen-based medications.
Ibuprofen is a widely used nonsteroidal antiinflammatory drug (NSAID) that is employed to treat pain, fever, and inflammation.
The API segment of this market is crucial as it ensures the availability of high-quality raw materials for pharmaceutical companies and contract manufacturing organizations worldwide.
Market Analysis
As of 2023, the global Ibuprofen API market was estimated at USD 682.46 million.
The market is projected to reach USD 930.35 million by 2029, exhibiting a Compound Annual Growth Rate (CAGR) of 5.30% over the forecast period.
The steady growth is attributed to increasing demand for pain relief medications, rising cases of arthritis and other inflammatory diseases, and growing pharmaceutical production capabilities globally.
The surge in over-the-counter (OTC) and prescriptionbased ibuprofen formulations further contributes to the market expansion.
Regional Analysis
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Competitor Analysis
Shandong Xinhua Pharmaceutical
Biocause
